Navigation Links
'Chemo Brain' May Linger 20 Years After Breast Cancer Treatment
Date:2/28/2012

By Denise Mann
HealthDay Reporter

MONDAY, Feb. 27 (HealthDay News) -- "Chemo brain," the name given to the mental fog and related memory problems that can occur during and after chemotherapy, may last for two decades after breast cancer treatment, new research suggests.

In the new study, 196 women with breast cancer who were treated with chemotherapy roughly 21 years earlier performed worse on tests of their memory, processing speed and other thinking ("cognitive") skills when compared to their counterparts who had never been diagnosed with cancer.

Participants had all been treated for breast cancer with a chemotherapy combination that included the drugs cyclophosphamide, methotrexate and 5-fluorouracil between 1976 and 1995. This regimen was considered the standard of care for breast cancer worldwide from the 1970s to the 1990s and was received by thousands of women during this time. Women in the study were aged 50 to 80.

"To our knowledge, this is the first study to suggest that subtle cognitive deficits may be among the long-term effects of chemotherapy, especially of the earlier regimens," study author Sanne Schagen, a group leader at the department of psychosocial research and epidemiology at the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital in Amsterdam, said in a news release from the American Society of Clinical Oncology.

She added that while the results don't suggest that breast cancer survivors need to be watched more closely for memory and thinking problems, they could guide referrals to support services as needed.

In general, women who received this chemotherapy regimen had lower scores on tests of their ability to recall words, information-processing speed, and coordination of thinking and hand movement, such as putting pegs in a board, than women who did not. The results on these tests were similar to those seen among people who had just completed chemotherapy, and their magnitude was comparable to roughly six years of age-related decline in mental function, the study authors noted.

The researchers also assessed the women for depression and self-reported memory problems as part of the study. The women who had received chemotherapy also had more memory complaints than their peers who did not have chemo, but these complaints were not related to how they performed on memory tests.

The study findings were published online Feb. 27 in the Journal of Clinical Oncology.

Dr. Tim Ahles, the director of the Neurocognitive Research Laboratory at Memorial Sloan-Kettering Cancer Center in New York City, said this new study is the first to illustrate that long-term breast cancer survivors are still experiencing difficulty with their thought processes. "It adds to the notion that these effects may be long term and permanent," he said.

The effects of so-called chemo brain vary from person to person, and not all people who receive chemotherapy will develop or be affected by these issues.

"If someone is a professional who has an extremely demanding job, even a small change may be problematic, whereas for someone who is retired and has a more relaxed lifestyle, it may be less of a problem," Ahles said. "For women who are newly diagnosed and looking at treatments, it is still important to know that not everyone experiences these deficits."

In terms of prevention and treatment, there are more questions than answers right now. "This is an active area of research, and now that we have identified this is a real problem, people are turning their attention to what we can do to help treat and reduce some of the negative impact," Ahles noted.

Dr. Marisa Weiss, president and founder of Breastcancer.org and director of breast radiation oncology and breast health outreach at Lankenau Medical Center in Wynnewood, Pa., said the new study "shows only a few pieces of this complex puzzle."

She said it wasn't clear whether subtle losses in mental function were due to cancer alone, the effects of other therapies such as anti-estrogen treatments, or other factors.

Although the study uncovered an association between the cancer treatment and memory problems in the study patients, it did not prove a cause-and-effect relationship.

"There were many differences between these two groups," Weiss said, including whether or not they underwent the specific chemotherapy regimen. "We still need to fill in the other puzzle pieces before we can see what the picture is going to look like."

Dr. Stefan Gluck, a professor in the department of medicine and assistant director of the University of Miami/Sylvester Comprehensive Cancer Center, said that the new findings confirm this is not a temporary problem. "It may be the combination of drugs used 20 years ago were more likely to cause these issues," he said. "Today's drugs may be less likely to cause long-term cognitive effects."

He also added that drugs taken by many breast cancer survivors to stave off a breast cancer recurrence after treatment may also contribute to chemo brain.

More information

Learn more about coping with chemotherapy side effects from the U.S. National Cancer Institute.

SOURCES: Tim Ahles, Ph.D., director, Neurocognitive Research Laboratory at Memorial Sloan-Kettering Cancer Center, New York City; Stefan Gluck, M.D., professor, department of medicine and assistant director, University of Miami/Sylvester Comprehensive Cancer Center; Marisa Weiss, president and founder, Breastcancer.org and director, breast radiation oncology and breast health outreach, Lankenau Medical Center, Wynnewood, Pa.; Feb. 27, 2012, Journal of Clinical Oncology, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
2. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
3. Scientists identify microRNA as possible cause of chemotherapy resistance
4. Study evaluates costs and benefits of new chemotherapy drugs
5. Older Colon Cancer Patients Less Likely to Get Chemo
6. Are New Chemo Treatments Cost-Effective?
7. BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR
8. Researchers find new chemotherapy combination shows promise in endometrial cancer
9. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
10. Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS
11. Chemo May Boost Survival After Lung Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Chemo Brain' May Linger 20 Years After Breast Cancer Treatment
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
Breaking Medicine Technology: